MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI), may help in
learning how well chemotherapy works to kill breast cancer cells and allow doctors to plan
better treatment. Drugs used in chemotherapy, such as epirubicin and docetaxel, may stop the
growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving
chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue
that needs to be removed.
PURPOSE: This clinical trial is studying MRI in evaluating early response to chemotherapy in
women receiving chemotherapy for infiltrating breast cancer.